ABOUT ME
Charalambos Gogos was born in Patras, Achaia, Greece. He obtained his medical degree from the Athens University School of Medicine in 1979, and served in the Greek army. He was trained in Medicine and Infectious Diseases in Patras University, Section of Infectious Diseases as well as Clatterbridge Hospital, NHS Trust and Royal Liverpool University Hospital, UK. He is currently Professor of Medicine at Patras University School of Medicine and Chairman of the Department of Medicine and Director of the Infectious Diseases Unit in Patras University Hospital. He has been the President of the Medical School of the University of Patras, since 2009 until 2013 and he is the Vice President of Hellenic Society of Chemotherapy, Vice President of Hellenic AIDS Society and Member of the Medical Society of Western Greece and Peloponnese. He is now the Vice President of the Board of Trustees of the University of Patras. His research interest is focused on immunology and infectious diseases, mainly on the pathogenesis of sepsis syndrome. He has published several articles on the immune response in sepsis, phagocytosis, the effect of antibiotics on sepsis syndrome, the role of biomarkers, etc in medical journals, like Journal of Infectious Diseases, Infection, Journal of Infection, Critical Care, Eur Journal of Clin Microbiology and Infectious Diseases etc. He is the President of the Greek Sepsis Team, member of the Global Sepsis Alliance. He is the author of more than 80 peer reviewed articles in PubMed and is cited by more than 1900 articles in SCOPUS. He is reviewer in many Scientific Journals. He has a special interest on Medical Education and he chairs the Curriculum Committee of Patras University Medical School since 2006.
-
Personal Website
-
Laboratory
-
Laboratory Website
-
Research Activity
-
Facilities
-
Selected research projects
-
Selected publications
1. Lagadinou M, Solomou EE, Velissaris D, Theodorou GL, Karakatza M, Gogos CA. Alterations in T-lymphocyte subpopulations in patients with complicated liver cirrhosis. Diagn Microbiol Infect Dis. 2013 Apr;75(4):348-56. 2. Kritselis I, Tzanetakou V, Adamis G, Anthopoulos G, Antoniadou E, Bristianou M, Kotanidou A, Lignos M, Polyzos K, Retsas T, Sassopoulou P, Papaioannou AI, Sinapidis D, Sereti K, Vittoros V, Ghanas P, Gogos C, Giamarellos-Bourboulis EJ. The level of endotoxemia in sepsis varies in relation to the underlying infection: Impact on final outcome. Immunol Lett. 2013 May;152(2):167-72. 3. Sargianou M, Panos G, Tsatsaris A, Gogos C, Papa A. Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece. Int J Infect Dis. 2013 Sep 10. [Epub ahead of print] 4. Akinosoglou K, Apostolakis E, Koutsogiannis N, Leivaditis V, Gogos CA. Right-sided infective endocarditis: surgical management.Eur J Cardiothorac Surg. 2012; Sep;42(3):470-9. 5. Akinosoglou KS, Solomou EE, Gogos CA. Malaria: a haematological disease. Hematology. 2012 Mar;17(2):106-14 6. Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK; for the HEPNET.Greece Cohort Study Group.Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis on oral antiviral(s) starting with lamivudine monotherapy: Results of the nationwide HEPNET.Greece cohort study.Gut. 2011 Aug;60(8):1109-16 7. Gogos CA, Antigone Kotsaki, Aimilia Pelekanou, et al. Early changes of the innate and adaptive immune systems in sepsis differ in relation to the underlying type of infection. Crit Care. 2010;14(3):R96. Epub 2010 May 26. 8. Leonidou L, Michalaki M, Leonardou A, Polyzogopoulou E, Fouka K, Gerolymos M, Leonardos P, Psirogiannis A, Kyriazopoulou V, Gogos CA. Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival. Am J Med Sci. 2008 Dec;336(6):467-71 9. Moutzouri AG, Athanassiou GA, Dimitropoulou D, Skoutelis AT, Gogos CA. Severe sepsis and diabetes mellitus have additive effects on red blood cell deformability. J Infect. 2008 Aug;57(2):147-51. 10. Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, Gogos CA.Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007 Oct;55(4):340-6. 11. Tsamandas A, Syrokosta I, Thomopoulos C, Zolota V, Dimitropoulou D, Liava A, Coupoulou AA, Siagris D, Petsas T, Karatza C, Gogos CA. Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy : a clinicopathologic study. Liver Int 2006;26:817-26 12. Mitsi G, Jelastopoulou Ε, Bassaris Η, Skoutelis Α, Gogos C. Patterns of antibiotic use among adults and parents in the community: a questionnaire-based survey in a Greek urban population. Int J Antimicrob Agents. 2005 May;25(5):439-43. 13. C.A. Gogos, A. Skoutelis, A. Lekkou, E. Drosou, I. Starakis, M.N. Marangos, H.P. Bassaris .The effect of ciprofloxacin versus ceftazidime on cytokine production in patients with severe gram-negative sepsis. Antimicrob Agents Chemother. 2004 Aug;48(8):2793-8. 14. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F and Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome in patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161-7 15. Tsamandas A, , Thomopoulos K, Zolota V, Kourelis T, Ravazoula P, Tepetes K, Petsas T, Karavias D, Karatza C, Bonikos DS and Gogos CA. The potential role of BCL2 and BAX mRNA on protein expression in chronic hepatitis type B and C. A clinicopathologic study. Mod Pathol 2003; 16(12): 1273-88 16. Gogos CA, Fouka K, Avgeridis K, Sakellaropoulos G, Nikiforides G, Bassaris H, Maniatis A, Skoutelis A. Prevalence of HBV and HCV infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003; 19: 551-7 17. Gogos CA, Giali S, Paliogianni F, Dimitrakopoulos G, Bassaris H, Vagenakis A. Interleukin-6 and C-Reactive Protein as markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis Diabetologia 2001; 44(8):1011-14. 18. Gogos CA, Drosou E, Bassaris HP, Skoutelis A,. Pro- versus anti-inflammatory cytokines in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181(1) 176-80. 19. Gogos CA, Ginopoulos P, Salsa B, Zoumbos N, Kalfarentzos F. Dietary ω-3 poyunsaturated fatty acids and Vitamin E restore immunodeficiency and prolong survival in severely ill patients with generalized malignancy. Cancer 1998;82:2:395-402. 20. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, and Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective study. Br J Surg 1997;84:1665-9
-
Cooperations with other Organizations and Institutes